Shigeto Mizuno - Concepedia

Author

Shigeto Mizuno

Kobe Pharmaceutical University

Also Known As

S MIZUNO, S Mizuno, S. MIZUNO, S. Mizuno, Shigeto MIZUNO, Shigeto Mizuno

119

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Kobe Pharmaceutical University Kobe University Kyoto Prefectural University of Medicine Kindai University Saiseikai Ibaraki Hospital

About

Shigeto Mizuno is an author at Kobe Pharmaceutical University specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	955
2	Health Sciences	6	6	118
3	Allergy	2	2	64
4	Public Health	1	1	34
5	Applied Physiology	1	1	12

Shigeto Mizuno

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitis Tsukasa Ishida, Masaru Yoshida, Makoto Arita, Inflammatory Bowel Diseases	2009	167
Serum metabolomics as a novel diagnostic approach for pancreatic cancer Shin Nishiumi, Masakazu Shinohara, Atsuki Ikeda, Metabolomics Tumor BiologyPancreatic CancerBiochemistryMedicineSerum Metabolomics	2010	128
Helicobacter pylori Infection and Gastric Cancer (A Nested Case-Control Study in a Rural Area of Japan) Yoshiyuki Watanabe, John H. Kurata, Shigeto Mizuno, Digestive Diseases and Sciences	1997	125
Evaluation of endoscopic ultrasonography in the pre-operative staging of carcinoma of the ampulla of Vater and common bile duct Hidekazu Mukai, Masatsugu Nakajima, Kenjiro Yasuda, Gastrointestinal Endoscopy Endoscopic UltrasonographyMedicineBiliary TractInterventional Endoscopic UltrasoundBiliary Cancer	1992	115
Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis Shigeto Mizuno, Ikuya Miki, Tsukasa Ishida, Digestive Diseases and Sciences Atrophic GastritisGastrointestinal OncologyHigh-risk GroupGastroenterologyPathology	2010	103
Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice Yuki Masuda, Munechika Inoue, Ayu Miyata, International Immunopharmacology Reduces MyelosupressionMedicineMetronomic TherapyAnti-cancer AgentPharmacology	2009	78
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1‐week regimen of proton pump inhibitor, amoxicillin and clarithromycin Hideaki Kawabata, Yasuki Habu, Hidenori Tomioka, Alimentary Pharmacology & Therapeutics	2003	77
Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice Tsukasa Ishida, Shin Nishiumi, Toshihito Tanahashi, European Journal of Pharmacology InflammationAnti-inflammatoryMedicine2,4-Dinitrofluorobenzene-induced Contact DermatitisSkin Pharmacology	2012	58
<i>Helicobacter pylori</i> infection is associated with colon adenomatous polyps detected by high‐resolution colonoscopy Shigeto Mizuno, Yoshinori Morita, Toshio Inui, International Journal of Cancer	2005	57
Soluble β-glucan from<i>Grifola frondosa</i>induces proliferation and Dectin-1/Syk signaling in resident macrophages via the GM-CSF autocrine pathway Yuki Masuda, Takuya Togo, Shigeto Mizuno, Journal of Leukocyte Biology	2011	57

Page 1